Modification of the effect of vitamin a acid on the skin tumor keratoacanthoma by applications of actinomcin D
Prutkin, L.
Cancer Research 31(8): 1080-1086
1971
ISSN/ISBN: 0008-5472 PMID: 4328822 Document Number: 43970
Document emailed within 1 workday
Related Documents
Mutoh, Y. 1980: Vitamin K and bone metabolism - on the effect of vitamin K deficiency and gamma-carboxyglutamic acid Nihon Seikeigeka Gakkai Zasshi 54(12): 1733-1743Hsia, Y.E.; Lilljeqvist, A.C.; Rosenberg, L.E. 1970: Vitamin B12-dependent methylmalonicaciduria: amino acid toxicity, long chain ketonuria, and protective effect of vitamin B12 Pediatrics 46(4): 497-507
Schaefer, H.; Zesch, A. 1975: Penetration of vitamin a acid into human skin Acta Dermato-Venereologica. Supplementum 74: 50-55
Ziel, K.; Yelverton, C.B.; Balkrishnan, R.; Feldman, S.R. 2005: Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin Journal of Drugs in Dermatology: Jdd 4(6): 727-731
Bollag, W.; Ott, F. 1975: Vitamin a acid in benign and malignant epithelial tumours of the skin Acta Dermato-Venereologica. Supplementum 74: 163-166
Verma, A.K. 1988: Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid Cancer Research 48(8): 2168-2173
Liu, X.; Zhang, L.; Zhang, M.; Ma, Y.; Xu, X.; Cai, Y. 2000: Co-modification of IL-2-TNF alpha fusion gene and B7.1 gene to murine breast tumor cells leads to improved tumor rejection and vaccine effect Chinese Medical Journal 113(2): 167-171
Riahi, R.R.; Cohen, P.R. 2013: Malignancies with skin lesions mimicking keratoacanthoma Dermatology Online Journal 19(11): 20397
Levin, L.V.; Clark, J.N.; Quill, H.R.; Newberne, P.M.; Wolf, G. 1983: Effect of retinoic acid on the synthesis of glycoproteins of mouse skin tumors during progression from promoted skin through papillomas to carcinomas Cancer Research 43(4): 1724-1732
Schaller, M.; Korting, H.C.; Wolff, H.; Schirren, C.G.; Burgdorf, W. 1996: Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: development in a single patient and treatment with oral isotretinoin Acta Dermato-Venereologica 76(1): 40-42
Balus, L.; Fazio, M.; Carducci, M.; Muscardin, L.; Piazza, P. 1981: Rare variant of multiple keratoacanthoma: eruptive keratoacanthoma Annales de Dermatologie et de Venereologie 108(12): 995-1000
Tataroglu, C.; Karabacak, T.; Apa, D.Düşmez. 2007: Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin Tumori 93(3): 284-289
Maydan, E.; Nootheti, P.K.; Goldman, M.P. 2006: Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid Journal of Drugs in Dermatology: Jdd 5(8): 804-806
Watanabe, M.; Oka, S. 1972: Effect of dietary modification on tumor growth in mice bearing sarcoma-180 and Ehrlich carcinoma Gan 63(5): 547-554
Malashenko, A.M.; Vasil'eva, S.V. 1985: Modification of the genetic effect of N-nitrosoethylurea in inbred mice by para-aminobenzoic acid Genetika 21(4): 582-585
Obochi, M.O.; Ratkay, L.G.; Levy, J.G. 1997: Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity Transplantation 63(6): 810-817
Khomulo, P.S.; Dzeranova, L.A. 1970: Effect of pangamic acid (vitamin B15) during starvation Biulleten' Eksperimental'noi Biologii i Meditsiny 70(11): 61-62
Mattila, M.J.; Nieminen, E.; Vapaatalo, H.I.; Brander, E. 1972: Modification by sodium salicylate and paraaminosalyicylic acid of the protein binding and antimycobacterial effect of isoniazid in vitro Arzneimittel-Forschung 22(10): 1769-1771
Shysh, A.M.; Pyvovar, S.M.; Kukoba, T.V.; Kotsiuruba, A.V.; Moĭbenko, O.O. 2004: Effect of modification in cell membrane fatty acid composition on adrenergic cardiac and vascular reactivity Fiziolohichnyi Zhurnal 50(6): 19-26
Schlager, S.I.; Ohanian, S.H. 1980: Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones Journal of Immunology 124(2): 626-634